Suicide: Where We Are, Where We’re Going, and What’s Keeping Us From Getting There

There is no area of research that brings a complex array of ethical issues into sharp focus more than conducting treatment trials when the focus is on decreasing suicidal behavior and preventing suicide. Historically, suicidal individuals have been excluded from treatment studies because their inclusion was thought to be unethical, unsafe, or too difficult to manage clinically.

This presentation will discuss where the field of suicide intervention research started, the successes and failures we have encountered thus far, as well as the critical issues that still need to be addressed in order to move the field forward. It will include a summary of the suicide intervention research trials to date and the directions the field is heading toward addressing the complex problem of suicidal behaviors.

APS regularly opens certain online articles for discussion on our website. Effective February 2021, you must be a logged-in APS member to post comments. By posting a comment, you agree to our Community Guidelines and the display of your profile information, including your name and affiliation. Any opinions, findings, conclusions, or recommendations present in article comments are those of the writers and do not necessarily reflect the views of APS or the article’s author. For more information, please see our Community Guidelines.

Please login with your APS account to comment.